ViroCell Biologics has entered a manufacturing collaboration with AvenCell Therapeutics Inc., delivering a novel retroviral ...

Asahi Kasei Life Science will construct a new spinning plant for its Planova virus removal filters in Nobeoka City, Miyazaki, ...

Novo Nordisk has appointed Maziar Mike Doustdar as President and CEO, effective August 7, 2025. Doustdar succeeds Lars ...

With three decades of experience, Labinger will help advance the company’s scientific platform toward key clinical milestones ...

Diorasis Therapeutics has partnered with Northway Biotech to establish a scalable cGMP production process for DTx’s lead ...

Enhances Ofichem’s innovation offering and expands its biotech footprint across Nordic countries.

Hansa Biopharma AB, which recently restructured and named a new CEO, has announced three leadership appointments.

Thomas brings more than 40 years of experience with biological process development and clinical manufacturing.

David King of Samsung Biologics shares insights on market demand and the technologies and capabilities needed to support ...

GSK plc has entered into agreements with China-based biotechnology company Hengrui Pharma to develop up to 12 innovative ...

Eli Lilly and Company has acquired Verve Therapeutics Inc., a Boston-based clinical-stage company developing genetic ...

Ateganosine is currently being evaluated in a pivotal Phase 2 THIO-101 clinical trial in the treatment of non-small cell lung ...